Aprea Therapeutics Inc. (APRE)
NASDAQ: APRE
· Real-Time Price · USD
1.71
0.02 (1.18%)
At close: Aug 15, 2025, 3:59 PM
1.67
-2.54%
After-hours: Aug 15, 2025, 07:38 PM EDT
Aprea Therapeutics Fail-to-Deliver
Total FTD Shares
14
Below Average
FTD / Avg. Volume
0.03%
Low Impact
1-Year Change
-53.3%
Negative Trend
FTD Chart
As of Jul 14, 2025,
Aprea Therapeutics Inc. has
14
shares failed to deliver, representing 0.03%
of the average daily volume of
51,496
shares. Over the past year, the monthly average FTD is
4,327
shares, with the current level 100% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 1.7 | 14 | -99.92% |
| Jun 30, 2025 | 1.69 | 17.4K | +184.81% |
| May 15, 2025 | 1.8 | 6.11K | -72.80% |
| Apr 29, 2025 | 1.7 | 22.47K | +448.78% |
| Mar 31, 2025 | 2.04 | 4.09K | +7082.46% |
| Feb 28, 2025 | 2.53 | 57 | -96.42% |
| Jan 31, 2025 | 3.91 | 1.59K | +125.04% |
| Dec 30, 2024 | 3.48 | 707 | +65.96% |
| Oct 30, 2024 | 4.01 | 426 | +142.05% |
| Sep 26, 2024 | 2.92 | 176 | +46.67% |
| Aug 26, 2024 | 3.55 | 120 | -51.22% |
| Jul 18, 2024 | 4 | 246 | -85.49% |
| Jun 24, 2024 | 4.14 | 1.7K | +4885.29% |
| May 16, 2024 | 5.59 | 34 | -65.66% |
| Apr 29, 2024 | 5.08 | 99 | -87.55% |
| Mar 21, 2024 | 6.35 | 795 | -42.60% |
| Feb 28, 2024 | 7.2 | 1.39K | +242.82% |
| Jan 30, 2024 | 5.15 | 404 | +6633.33% |
| Dec 19, 2023 | 3.9 | 6 | -97.99% |
| Nov 27, 2023 | 3.69 | 299 | +164.60% |
| Oct 30, 2023 | 3.58 | 113 | -85.15% |
| Sep 22, 2023 | 4.15 | 761 | -45.80% |
| Aug 14, 2023 | 3.85 | 1.4K | -30.60% |
| Jul 24, 2023 | 3.12 | 2.02K | +886.83% |
| Jun 30, 2023 | 3.15 | 205 | +2828.57% |
| May 22, 2023 | 3.75 | 7 | -98.61% |
| Mar 31, 2023 | 4.44 | 502 | -76.93% |
| Feb 24, 2023 | 5.1 | 2.18K | -78.24% |
| Jan 13, 2023 | 9.76 | 10K | n/a |